We’ve known for some time that if your patient has a parental history of a mood disorder or suicide attempt, his or her risk of a suicide attempt increases, and a new study adds some more information that might help us prevent bad outcomes.
In December 2014, the US Food and Drug Administration (FDA) issued a safety announcement warning that the antipsychotic drug ziprasidone (Geodon) has been associated with a rare but potentially fatal skin reaction.
Julianna Troy, MD
Staff Psychiatrist, Counseling and Psychological Services, Purdue University, Lafayette, IN
Dr. Troy has disclosed that she has no relevant relationships or commercial interests in any companies related to this educational activity.
Do you use email to communicate with your patients? Chances are good that you don’t.
William H. Reid, MD, MPH
Psychiatrist in Private Practice, Horseshoe Bay, TX, Past-President, American Academy of Psychiatry and the Law, Clinical Professor of Psychiatry, Texas Tech University Health Sciences Center
Dr. Reid has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity. He also notes that he is not a lawyer, and nothing in his words should be construed as legal advice.
Get some practical advice on how to assess a patient’s suicide risk and document your care to help protect against a malpractice lawsuit, in an interview with William H. Reid, MD, MPH, a clinical professor of psychiatry at Texas Tech University Health Sciences Center.
Botulinum toxin A, commonly known as Botox, may be more than an anti-aging treatment. A new study has found that when Botox is injected between the eyebrows, it not only has a cosmetic effect—it also yields a long-lasting antidepressant effect.
Robin Berlin, MD
Assistant clinical professor of psychiatry, George Washington University School of Medicine, Washington, DC
Dr. Berlin has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
In bipolar disorder, depression is often the neglected stepchild. Mania gets more attention, perhaps because it presents so dramatically. Imagine two bipolar patients in an emergency room: one withdrawn and depressed, sitting quietly, and another ranting and pacing the room. Which one would be seen first?